본문으로 바로가기
Product Thumnail Image
Product Thumnail Image

HB BestPlex™ COVID-19 RT-PCR Kit

By HB BestPlex™

Negotiable | Min. Order

Description
INTENDED USE: The HB BestPlexTM COVID-19 RT-PCR Kit is a multiplex real-time RT-PCR test intended for the presumptive qualitative detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal or oropharyngeal swab from individuals exhibiting signs and symptoms for COVID-19. Results of this RT-PCR test are for the identification of SARS-CoV-2 RNA. A positive result indicates the presence of SARS-CoV-2 RNA in the collected specimen. However, this does not rule out the possibility of co-infection with other viruses or bacteria. All positive results need to be reported to proper public health authorities in the United States. Negative results by this kit do not preclude SARS-CoV-2 infection. Definitive diagnosis must be considered with other clinical observations, patient history and epidemiological information. The HB BestPlexTM COVID-19 RT-PCR Kit is intended to use by well-trained laboratory personnel for the techniques and diagnostic procedure of real-time PCR. Testing with the HB BestPlexTM COVID-19 RT-PCR Kit is limited to laboratories - certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests or by similarly qualified non U.S. laboratories.The HB BestPlexTM COVID-19 RT-PCR Kit is a multiplex real-time RT-PCR test intended for the presumptive qualitative detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal or oropharyngeal swab from individuals exhibiting signs and symptoms for COVID-19. Results of this RT-PCR test are for the identification of SARS-CoV-2 RNA. A positive result indicates the presence of SARS-CoV-2 RNA in the collected specimen. However, this does not rule out the possibility of co-infection with other viruses or bacteria. All positive results need to be reported to proper public health authorities in the United States. Negative results by this kit do not preclude SARS-CoV-2 infection. Definitive diagnosis must be considered with other clinical observations, patient history and epidemiological information.The HB BestPlexTM COVID-19 RT-PCR Kit is intended to use by well-trained laboratory personnel for the techniques and diagnostic procedure of real-time PCR. Testing with the HB BestPlexTM COVID-19 RT-PCR Kit is limited to laboratories - certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests or by similarly qualified non U.S. laboratories. SPECIFICATION:- Results within 1.5 hour after extraction- One-Step RT Real-Time PCR (Only require RNA template)- All reagents (cDNA synthesis & qPCR analysis) are included- The validity of RT-PCR reaction is precisely verified by using Positive Control COMPATIBILITY: - CFX96 Real-time PCR Detection System-IVD [Bio-Rad]- Applied Biosystems 7500 Fast Dx platform-IVD [ABI] PACKAGE:- 150 rxns/Kit [HBVRP-CoV101]- 450 rxns/Kit [HBVRP-CoV201]- 3,600 rxns/Kit [HBVRP-CoV301]
Place of Origin
South Korea

Size
78.0 * 55.0 * 64.0 mm
Weight
500 g
Payment Terms
T/T
TKPAY Sample
Samples INFO

Negotiable | (Min. Order)

Payment
  • visa
  • master
  • jcb
  • unionPay
  • 4 HeimBiotek

    Supplier Activity

    Country South Korea South Korea

    KITA DUNS

    Send Message
    PRODUCT DESCRIPTION
    COMPANY INFORMATION
    Product Information

    INTENDED USE:                                                                                                                                                                                     

    The HB BestPlexTM COVID-19 RT-PCR Kit is a multiplex real-time RT-PCR test intended for the presumptive qualitative detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal or oropharyngeal swab from individuals exhibiting signs and symptoms for COVID-19. Results of this RT-PCR test are for the identification of SARS-CoV-2 RNA. A positive result indicates the presence of SARS-CoV-2 RNA in the collected specimen. However, this does not rule out the possibility of co-infection with other viruses or bacteria. All positive results need to be reported to proper public health authorities in the United States. Negative results by this kit do not preclude SARS-CoV-2 infection. Definitive diagnosis must be considered with other clinical observations, patient history and epidemiological information. The HB BestPlexTM COVID-19 RT-PCR Kit is intended to use by well-trained laboratory personnel for the techniques and diagnostic procedure of real-time PCR. Testing with the HB BestPlexTM COVID-19 RT-PCR Kit is limited to laboratories - certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests or by similarly qualified non U.S. laboratories.

    The HB BestPlexTM COVID-19 RT-PCR Kit is a multiplex real-time RT-PCR test intended for the presumptive qualitative detection of nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in nasopharyngeal or oropharyngeal swab from individuals exhibiting signs and symptoms for COVID-19.

    Results of this RT-PCR test are for the identification of SARS-CoV-2 RNA. A positive result indicates the presence of SARS-CoV-2 RNA in the collected specimen. However, this does not rule out the possibility of co-infection with other viruses or bacteria. All positive results need to be reported to proper public health authorities in the United States. Negative results by this kit do not preclude SARS-CoV-2 infection. Definitive diagnosis must be considered with other clinical observations, patient history and epidemiological information.

    The HB BestPlexTM COVID-19 RT-PCR Kit is intended to use by well-trained laboratory personnel for the techniques and diagnostic procedure of real-time PCR. Testing with the HB BestPlexTM COVID-19 RT-PCR Kit is limited to laboratories - certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests or by similarly qualified non U.S. laboratories.

     

    SPECIFICATION:

    - Results within 1.5 hour after extraction
    - One-Step RT Real-Time PCR (Only require RNA template)
    - All reagents (cDNA synthesis & qPCR analysis) are included
    - The validity of RT-PCR reaction is precisely verified by using Positive Control

     

    COMPATIBILITY:                                                                                                                                                                                          

    - CFX96 Real-time PCR Detection System-IVD [Bio-Rad]
    - Applied Biosystems 7500 Fast Dx platform-IVD [ABI]

     

    PACKAGE:

    - 150 rxns/Kit [HBVRP-CoV101]
    - 450 rxns/Kit [HBVRP-CoV201]
    - 3,600 rxns/Kit [HBVRP-CoV301]

     

    Image
    • One Page_HB BestPlex COVID-19 RT-PCR Kit_2020-06-18

    Feature


    Spec


    Company
    HeimBiotek

    HeimBiotek

    Country South Korea South Korea

    Supplier Activity

    President
    Jae Hoon Lee
    Address
    Pangyo Silicon Park A-201 35, Pangyo-ro 255Beon-gil, Bundang-Gu Seongnam-Si, Gyeonggi-Do, KOREA
    Product Category
    Education Supplies,Other Education Supplies,Chemical Reagents & Products,Other Chemical Machinery Equipment
    Year Established
    2014
    No. of Total Employees
    1-50
    Company introduction

    HeimBiotec,Ink. has been devoted to the global leader in genetic analysis and molecular diagnostics and is a R & D enterprise based on original technology secured through efficient and strategic research and development.


    We are developig and researching Companion Diagnostics based on SBDEⓇ(Specific Bi-Direction Extension Technique. And we have released micro RNA detection assay kit which is based on the Reverse Tranx-x-scription quantitative PCR and It is higher than other products in the worldas the third commercializtion
    we will continue to grow steadily through continuous R & D investment and new product development, We will achieve globalization of technology and product as commercializing genetic anaylsis and molecular diagnostic product with high technology and competitiveness. 

    Main Markets
    • Canada Canada ,
    • China China ,
    • Germany Germany ,
    • Japan Japan ,
    • Singapore Singapore ,
    • Thailand Thailand ,
    • Taiwan Taiwan ,
    • U.S.A U.S.A
    Factory Information
    Research Institute

    Verified Certificate

    Other Products viewed with This Product